Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis
- PMID: 32473875
- PMCID: PMC7245650
- DOI: 10.1016/j.dhjo.2020.100942
Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis
Abstract
Background: Despite possibly higher risk of severe outcomes from COVID-19 among people with intellectual and developmental disabilities (IDD), there has been limited reporting of COVID-19 trends for this population.
Objective: To compare COVID-19 trends among people with and without IDD, overall and stratified by age.
Methods: Data from the TriNetX COVID-19 Research Network platform was used to identify COVID-19 patients. Analysis focused on trends in comorbidities, number of cases, number of deaths, and case-fatality rate among patients with and without IDD who had a positive diagnosis for COVID-19 through May 14, 2020.
Results: People with IDD had higher prevalence of specific comorbidities associated with poorer COVID-19 outcomes. Distinct age-related differences in COVID-19 trends were present among those with IDD, with a higher concentration of COVID-19 cases at younger ages. In addition, while the overall case-fatality rate was similar for those with IDD (5.1%) and without IDD (5.4%), these rates differed by age: ages ≤17 - IDD 1.6%, without IDD <0.01%; ages 18-74 - IDD 4.5%, without IDD 2.7%; ages ≥75- IDD 21.1%, without IDD, 20.7%.
Conclusions: Though of concern for all individuals, COVID-19 appears to present a greater risk to people with IDD, especially at younger ages. Future research should seek to document COVID-19 trends among people with IDD, with particular attention to age related trends.
Keywords: COVID-19; Coronavirus; Developmental disability; Intellectual disability.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State.Disabil Health J. 2020 Oct;13(4):100969. doi: 10.1016/j.dhjo.2020.100969. Epub 2020 Jun 24. Disabil Health J. 2020. PMID: 32600948 Free PMC article.
-
Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.J Intellect Disabil Res. 2020 Jul;64(7):489-496. doi: 10.1111/jir.12740. Epub 2020 Jun 3. J Intellect Disabil Res. 2020. PMID: 32490559 Free PMC article.
-
COVID-19 and the Field of Intellectual and Developmental Disabilities: Where Have We Been? Where Are We? Where Do We Go?Intellect Dev Disabil. 2020 Aug 1;58(4):257-261. doi: 10.1352/1934-9556-58.4.257. Intellect Dev Disabil. 2020. PMID: 32750709
-
Virtual health care for adult patients with intellectual and developmental disabilities: A scoping review.Disabil Health J. 2021 Oct;14(4):101132. doi: 10.1016/j.dhjo.2021.101132. Epub 2021 Jun 6. Disabil Health J. 2021. PMID: 34127406 Free PMC article. Review.
-
How COVID-19 May Change the World of Services to People With Intellectual and Developmental Disabilities.Intellect Dev Disabil. 2020 Oct 1;58(5):355-360. doi: 10.1352/1934-9556-58.5.355. Intellect Dev Disabil. 2020. PMID: 33032314 Review.
Cited by
-
Predictors of vaccine hesitancy among disability support workers in Australia: A cross-sectional survey.Disabil Health J. 2023 Jan;16(1):101369. doi: 10.1016/j.dhjo.2022.101369. Epub 2022 Sep 2. Disabil Health J. 2023. PMID: 36202734 Free PMC article.
-
Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke.Cureus. 2020 Sep 3;12(9):e10231. doi: 10.7759/cureus.10231. Cureus. 2020. PMID: 33042672 Free PMC article.
-
Effects of the COVID-19 pandemic on mental healthcare and services: results of a UK survey of front-line staff working with people with intellectual disability and/or autism.BJPsych Bull. 2021 May 12;46(4):1-7. doi: 10.1192/bjb.2021.52. Online ahead of print. BJPsych Bull. 2021. PMID: 33977886 Free PMC article.
-
A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States.Sci Rep. 2021 May 13;11(1):10231. doi: 10.1038/s41598-021-89553-1. Sci Rep. 2021. PMID: 33986390 Free PMC article.
-
Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.Front Immunol. 2022 Aug 17;13:918692. doi: 10.3389/fimmu.2022.918692. eCollection 2022. Front Immunol. 2022. PMID: 36059456 Free PMC article.
References
-
- Larson S.A., Lakin K.C., Anderson L., Kwak Lee N., Lee J.H., Anderson D. Prevalence of mental retardation and developmental disabilities: estimates from the 1994/1995 National health interview survey disability supplements. Am J Ment Retard. 2001;106(3):231–252. - PubMed
-
- Fujiura G.T., Taylor S.J. Continuum of intellectual disability: demographic evidence for the “Forgotten Generation”. Ment Retard. 2003;41(6):420–429. - PubMed
-
- Boyle C.A., Boulet S., Schieve L.A. Trends in the prevalence of developmental disabilities in US children, 1997–2008. Pediatrics. 2011;127(6):1034–1042. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical